Latest news with #TCRF
Daily Express
3 days ago
- Entertainment
- Daily Express
Crocker Range Festival set to return June 26
Published on: Thursday, June 05, 2025 Published on: Thu, Jun 05, 2025 Text Size: Festival organising chairman Rafie Robert said the initiative aims to provide a free and inclusive experience for all visitors, strengthening intergenerational ties and community spirit. KENINGAU: The Crocker Range Festival (TCRF) is set to return for its 8th season with a vibrant four-day celebration from June 26 to 29 at Dataran Keningau, featuring a dynamic mix of cultural showcases and community programmes. The event is expected to draw both local and national attention, especially from tourists and culture enthusiasts, with its focus on celebrating the rich ethnic heritage of Sabah's interior. Advertisement This year's festival will include traditional performances, craft competitions, ethnic sports, and highlight programmes such as the popular Miss & Mister Crocker Range pageant and an exhibition of local products. New to this year's edition are three added components – the Sabah Cultural Fiesta, Keningau Youth Fiesta, and Kids Fiesta. Festival organising chairman Rafie Robert said the initiative aims to provide a free and inclusive experience for all visitors, strengthening intergenerational ties and community spirit. 'An exclusive performance by two acclaimed local ethnic artistes, Alena Murang and Belle Sisoski, is set to be one of the main highlights of the event, with both expected to captivate the audience through traditional music that celebrates and elevates Borneo's rich cultural heritage. 'We are excited to carry forward the legacy of TCRF as a platform to celebrate our culture and foster community unity. Having incredible talents like Alena and Belle join us will add depth to the cultural experience,' Rafie said. He added that the festival also offers a meaningful opportunity for local entrepreneurs to showcase and sell their products directly to the public, contributing to rural economic growth. TCRF 2025, he said, is more than a cultural celebration – it is aligned with the State Government's vision of strengthening tourism as a key driver of economic development under the Sabah Maju Jaya (SMJ) Development Plan. 'This is a holistic effort to enhance tourism, preserve cultural identity and boost the local economy,' he said. The public is encouraged to attend and experience the vibrant cultural diversity of Sabah during the event. For more information, visit the festival's official Facebook page at or contact the organising secretariat at 019-8523303. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
Time of India
30-04-2025
- General
- Time of India
Tulu content digitised with student collaboration
Mangaluru: The Tulu Cultural Research Foundation (TCRF), headed by software engineer Mahesh Mulki , is working closely with students from various colleges in the district to digitise Tulu language content and preserve the region's cultural heritage. As part of its initiatives, the foundation recently released the second edition of 'Jeetige', a beginner-friendly primer designed to help learners master the Tulu script. Mahesh Mulki said, "TCRF is an independent social enterprise established to promote research on the themes of language, culture, and people. We aim to document, archive, and revive the intangible cultural values of Tulunadu through folklore research, publishing, and community engagement. Archiving is important, especially when there are efforts to make Tulu the second official language of the state." In 2023, the foundation published the first edition of 'Jeetige', printing 1,000 copies. Encouraged by the response, they released an upgraded second edition this year with another 1,000 copies. "MP Capt Brijesh Chowta also picked up a few copies, which are priced at Rs 50 each," Mahesh said. Appreciating the effort, the MP called upon the public to make an effort to get closer to our mother tongue and the wisdom it holds in its tales and traditions. Meanwhile, to address the challenge of scattered online resources on Tulunadu, TCRF launched a dedicated website, The website was developed by Akshay Rai, an engineering student. "While various platforms allow users to edit content, this often leads to the spread of misinformation. We aim to provide authentic, verified information, and for that, we are mainly collaborating with students," he said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 2025 Top Trending local enterprise accounting software [Click Here] Esseps Learn More Undo "Among the foundation's members is Prahlad Tantri, an engineering student in Mysuru, who contributed to developing Tulu fonts. Among others on the technical side are Deepak Padukone and Nishanth Ratnakar, who actively support the foundation's initiatives. The team also held a Tulu conclave this year, which will be an annual affair henceforth. We are also working on promoting Tulu culture through outreach programmes, publications, and events to educate the public," he added.
Associated Press
09-04-2025
- Business
- Associated Press
Groundbreaking Study on Risk Assessment of Breast Cancer Aims to Revolutionize Diagnosis and Treatment
WESTPORT, CT / ACCESS Newswire / April 9, 2025 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ('CYduct', or the 'Company'), a precision medicine-based women's health company focused on the development of breast cancer risk assessment test and diagnostic tools, today announced it is expanding its patient study research on targeted breast cancer biomarkers for risk assessment leading to early detection. A new study directed by CYduct Diagnostics, Inc. is set to transform the landscape of breast cancer risk assessment, focusing on the development of innovative early diagnostic techniques that could improve survival rates and treatment outcomes. This groundbreaking research, supported by the Dr. Susan Love Fund for Breast Cancer Research at Tower Cancer Research Foundation, seeks to identify specific biomarker combinations associated with breast cancer development allowing for the earliest detection possible, offering new hope to millions of women worldwide. Breast cancer remains one of the most common and devastating cancers affecting women globally. According to the World Health Organization, nearly 2.5 million women are diagnosed annually, with early detection playing a critical role in overall survival prognosis. Despite advancements in screening methods such as mammography, many cases are still diagnosed at a later stage when the disease has spread, making treatment more difficult, and survival rates less than optimum. The new study, led by Jill Dietz, M.D. and Shari Yosinski, Ph.D. aims to utilize innovative next-generation automated ELISA technology designed to deliver accurate, reproducible data, to assist in identifying breast cancer indications in noninvasively collected patient samples before it becomes detectable through traditional methods. The study has obtained the required patient samples and aims to offer crucial insights into risk assessment and better screenings that could save lives. 'We are excited about the possibilities this study holds for improving breast cancer risk assessment,' said Dr. Jill Dietz, lead medical researcher and Chief Medical Officer. By identifying the disease at its earliest stages, we can significantly improve treatment outcomes, reduce the need for aggressive therapies, and ultimately save lives. This research could mark a transformative shift in the way we approach breast cancer diagnosis and contribute to incorporating a temporal aspect into breast cancer risk management. It allows women to determine if there are changes within their mammary ducts or if conditions remain stable.' About the Tower Cancer Research Foundation (TCRF): TCRF was established in 1996 by a driven group of physicians, patients, and volunteers with a personal stake in cancer to fund high impact research and survivorship support programs. Today, TCRF continues to advance groundbreaking science and fund essential support for people affected by cancer. TCRF provides financial support to researchers, serving as a platform for further funding and discoveries internationally. Now, Tower Cancer Research Foundation extends its mission with the establishment of the Dr. Susan Love Fund for Breast Cancer Research. Dr. Susan Love established herself as a surgeon in Los Angeles, becoming a trailblazer and a beacon in the work to end breast cancer. The Dr. Susan Love Fund and TCRF's other programs are designed to maximize impact beyond the initial investment, benefiting researchers, patients and families today, with the potential to lead to even greater impact tomorrow. About CYduct Diagnostics, Inc.: CYduct Diagnostics Inc. is a medical device company pursuing innovations within the women's healthcare market, primarily breast healthcare and wellness. CYduct is focused on breast health and wellness through new testing methods that prioritize clinical integrity and patient privacy and convenience. The Company's history is rooted in providing quality medical products to healthcare markets across the United States. For more than 30 years, from medical schools to hospitals, physicians have relied on the Company to develop medical devices, and procedural techniques for screening, diagnosis, treatment and management of disease and medical conditions. Additional information on its line of products will be available on the Company's website at: FORWARD-LOOKING STATEMENTS; ADDITIONAL INFORMATION This press release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as 'could,' 'may,' 'will,' 'expects,' 'anticipates,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'proposed,' 'planned,' 'potential' and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about CYduct's beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although CYduct believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. CYduct cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company's securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company's Annual Report filing and other filings with the OTC Markets Group (available at The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law. CYduct Diagnostics, Inc.
